Symptomatic fructose malabsorption in irritable bowel syndrome: A prospective study

United European Gastroenterology Journal

Volumn 2, Issue 2, 2014, Pages 131-137

  Melchior, Chloé ^a   Gourcerol, Guillaume ^a   Déchelotte, Pierre ^a   Leroi, Anne Marie ^a   Ducrotté, Philippe ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Breath tests; FODMAPs; Fructose malabsorption; Irritable bowel syndrome

Indexed keywords

FRUCTOSE; HYDROGEN; METHANE; METRONIDAZOLE; QUINOLONE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ARTICLE; BACTERIAL OVERGROWTH; BLOATING; BREATH ANALYSIS; CLINICAL ASSESSMENT; CONSTIPATION; DIARRHEA; FEMALE; GASTROINTESTINAL QUALITY OF LIFE INDEX; HEREDITARY FRUCTOSE INTOLERANCE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 85006200810     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640614521124     Document Type: Article

References (24)

1. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480–1491.
2. Ford AC and Talley NJ. IBS in 2010: Advances in pathophysiology, diagnosis and treatment. Nat Rev Gastroenterol Hepatol 2010; 8: 76–78.
3. Choung RS, Locke GR, 3rd, Zinsmeister AR, et al. Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: A psychological component is the rule. Am J Gastroenterol 2009; 104: 1772–1779.
4. Ragnarsson G and Bodemar G. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients’ description of diarrhea, constipation and symptom variation during a prospective 6-week study. Eur J Gastroenterol Hepatol 1998; 10: 415–421.
5. Shepherd SJ, Parker FC, Muir JG, et al. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: Randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008; 6: 765–771.
6. Gibson PR and Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol 2010; 25: 252–258.
7. Cho HS, Park JM, Lim CH, et al. Anxiety, depression and quality of life in patients with irritable bowel syndrome. Gut Liver 2011; 5: 29–36.
8. Slim K, Bousquet J, Kwiatkowski F, et al. [First validation of the French version of the Gastrointestinal Quality of Life Index (GIQLI)]. Gastroenterol Clin Biol 1999; 23: 25–31.
9. Gibson PR, Newnham E, Barrett JS, et al. Review article: Fructose malabsorption and the bigger picture. Aliment Pharmacol Ther 2007; 25: 349–363.
10. Nucera G, Gabrielli M, Lupascu A, et al. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005; 21: 1391–1395.
11. Thompson DG, O’Brien JD and Hardie JM. Influence of the oropharyngeal microflora on the measurement of exhaled breath hydrogen. Gastroenterology 1986; 91: 853–860.
12. Romagnuolo J, Schiller D and Bailey RJ. Using breath tests wisely in a gastroenterology practice: An evidencebased review of indications and pitfalls in interpretation. Am J Gastroenterol 2002; 97: 1113–1126.
13. Posserud I, Stotzer PO, Bjornsson ES, et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56: 802–808.
14. Frieling T, Kuhlbusch-Zicklam R, Kalde S, et al. Fructose malabsorption: How much fructose can a healthy subject tolerate? Digestion 2011; 84: 269–272.
15. Rao SS, Attaluri A, Anderson L, et al. Ability of the normal human small intestine to absorb fructose: Evaluation by breath testing. Clin Gastroenterol Hepatol 2007; 5: 959–963.
16. Pimentel M, Chow EJ and Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 3503–3506.
17. Knudsen CD and Di Palma JA. Carbohydrate challenge tests: Do you need to measure methane? South Med J 2012; 105: 251–253.
18. De Lacy Costello BP, Ledochowski M and Ratcliffe NM. The importance of methane breath testing: A review. J Breath Res 2013; 7: 024001.
19. Bate JP, Irving PM, Barrett JS, et al. Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption. Eur J Gastroenterol Hepatol 2010; 22: 318–326.
20. Wilder-Smith CH, Materna A, Wermelinger C, et al. Fructose and lactose intolerance and malabsorption testing: The relationship with symptoms in functional gastrointestinal disorders. Aliment Pharmacol Ther 2013; 37: 1074–1083.
21. Jones HF, Ross N, Butler RN, et al. Intestinal fructose transport and malabsorption in humans. Am J Physiol Gastrointest Liver Physiol 2011; 300: G202–G206.
22. Barrett JS, Irving PM, Shepherd SJ, et al. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther 2009; 30: 165–174.
23. Tomba C, Baldassarri A, Coletta M, et al. Is the subjective perception of lactose intolerance influenced by the psychological profile? Aliment Pharmacol Ther 2012; 36: 660–669.
24. Yang J, Deng Y, Chu H, et al. Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2012; 11: 262–268.